Treatment of Nine Patients with Refractory Plasma Cell Mastitis by Fistulectomy Combined with Nipple Correction
10.3969/j.issn.1005-6483.2023.11.018
- VernacularTitle:瘘管切除联合乳头矫形术治疗难治性浆细胞性乳腺炎九例
- Author:
Jierong GUO
1
;
Chenping SUN
;
Sheng LIU
;
Sawuer REZIYA
Author Information
1. 200032 上海中医药大学附属龙华医院中西医结合乳腺科
- Keywords:
refractory plasma cell mastitis;
fistulectomy combined with nipple correction
- From:
Journal of Clinical Surgery
2023;31(11):1068-1071
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical treatment of patients with refractory plasma cell mastitis by fistulectomy combined with nipple correction,observe its clinical efficacy,and analyze its clinical practicability.Methods Nine patients with refractory plasma cell mastitis were treated from August in 2020 to March in 2022.Before operation,fistulectomy and nipple correction were performed after the local inflammation was controlled by oral Chinese medicine.After operation,routine surgical dressing changes were performed,and the clinical efficacy,satisfaction evaluation of postoperative breast appearance and recurrence rate were observed.Results All the nine patients were cured after operation and they were satisfied with their breast shape,and there was no recurrence within one year after operation.Conclusion Fistulectomy combined with nipple correction is a safe and effective method for the treatment of patients with refractory plasma cell mastitis.
